Document is current
Any future updates will be listed below
-
Authors
Kang, Albert S. W.
Bernasconi, Janette G.
Jack, William
Kanavarioti, Anastassia
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Human Genome Research Institute (1R43HG010841)
- License Information
-
More Information
Article History
Received: 1 October 2020
Accepted: 28 October 2020
First Online: 13 November 2020
Competing interests
: Anastassia Kanavarioti has filed a non-provisional patent application as sole inventor; she is the Founder and Director of Yenos Analytical LLC, a company delivering custom analytical solutions for native, synthetic, or transcribed nucleic acids, and engaged in the development and manufacturing of labeled/tagged nucleic acids. There is no competing interest or relationship (commercial, financial, or non-financial) between the three companies, namely Oxford Nanopore Technologies, New England BioLabs, and Yenos Analytical LLC and their employees.
